- Home
- MNKD vs DOLE Comparison
MNKD vs DOLE Comparison
Compare MNKD & DOLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- DOLE
- Stock Information
- Founded
- MNKD 1991
- DOLE 1851
- Country
- MNKD United States
- DOLE Ireland
- Employees
- MNKD N/A
- DOLE N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- DOLE Farming/Seeds/Milling
- Sector
- MNKD Health Care
- DOLE Consumer Staples
- Exchange
- MNKD Nasdaq
- DOLE Nasdaq
- Market Cap
- MNKD 1.8B
- DOLE 1.5B
- IPO Year
- MNKD 2004
- DOLE 2021
- Fundamental
- Price
- MNKD $6.80
- DOLE $14.73
- Analyst Decision
- MNKD Strong Buy
- DOLE Buy
- Analyst Count
- MNKD 5
- DOLE 4
- Target Price
- MNKD $8.40
- DOLE $16.75
- AVG Volume (30 Days)
- MNKD 2.9M
- DOLE 535.2K
- Earning Date
- MNKD 11-07-2024
- DOLE 11-13-2024
- Dividend Yield
- MNKD N/A
- DOLE 2.17%
- EPS Growth
- MNKD N/A
- DOLE 71.64
- EPS
- MNKD 0.08
- DOLE 1.96
- Revenue
- MNKD $267,200,000.00
- DOLE $8,380,134,000.00
- Revenue This Year
- MNKD $46.83
- DOLE $2.14
- Revenue Next Year
- MNKD $14.40
- DOLE $0.68
- P/E Ratio
- MNKD $85.77
- DOLE $9.44
- Revenue Growth
- MNKD 51.35
- DOLE 2.00
- 52 Week Low
- MNKD $3.17
- DOLE $10.71
- 52 Week High
- MNKD $7.63
- DOLE $17.12
- Technical
- Relative Strength Index (RSI)
- MNKD 47.15
- DOLE 31.67
- Support Level
- MNKD $6.61
- DOLE $14.56
- Resistance Level
- MNKD $7.44
- DOLE $16.93
- Average True Range (ATR)
- MNKD 0.35
- DOLE 0.34
- MACD
- MNKD -0.05
- DOLE -0.18
- Stochastic Oscillator
- MNKD 18.63
- DOLE 7.29
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About DOLE Dole plc
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW and Fresh Vegetables. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.